Work

Supplementary Table S2 from 131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study

Year: 2026

Type: supplementary-materials

Abstract: Demographic and Baseline characteristics of the Safety Population

DOI: 10.1158/1078-0432.32708705

Authors: Evan Y. Yu, Vivek Narayan, Giuseppe Esposito, Russell Szmulewitz, Yang Lu, Michael B. Lilly, Jeremie Calais, Gennady Bratslavsky, Yusuf Menda, Minal Vasanawala, Frédéric Pouliot, David Laidley, Neil Fleshner, Fred Saad, Jean-Claude Provost, Iryna Teslenko, Nand Kishore Rawat, Gary Ulaner

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165034556

Cites:

Cited by:

Related to: 10